Dr. Marsha Gordon is Professor and Vice Chairman of Department of Dermatology at the Icahn School of Medicine at Mount Sinai, where she has worked since 1988. From 1998 to 2002, she served as both Clinical Director of the Department of Dermatology at Mount Sinai and also Director of the Residency Program, and later served as Co-Director of the Residency Program from 2002 to 2006. Other posts she has held during her career at Mount Sinai include membership in the Executive Committee of the Department of Dermatology, member of the Dermatology Residency Selection Committee, Faculty Practice Assembly member and Chairperson of the Dermatology Quality Assurance Committee. From 1999-2003 she served on the Melanoma/Skin Cancer Committee of the American Academy of Dermatology.
From 1988 until 2015, Dr. Gordon was Chief Consultant for the Department, responsible for the Inpatient Dermatology Consult Service. In 2015, following Mount Sinai's merger with several other New York hospitals, including St. Luke's, Roosevelt and Beth Israel, Dr. Gordon stepped down from her post as Chief Consultant in order to focus time and energy on improving the patient experience and patient satisfaction in the Departments of Dermatology over all campuses of Mount Sinai, a new position which she is currently enjoying.
She is a graduate of The University of Pennsylvania School of Medicine (now the Perelman School of Medicine at the University of Pennsylvania) and completed her dermatology residency at The Mount Sinai School of Medicine in 1988.
The current focus of her outpatient practice is cosmetic dermatology, specializing in filler and botulinum toxin injections for the mature face.
Dr. Gordon enjoys traveling, art, theater and writing.
American Board of Dermatology
MD, Hospital of University of Pennsylvania
Residency, Internal Medicine
Cooper Hospital-Univ. Med. Center
Mount Sinai Hospital
New York Magazine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Gordon during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.